What are the primary risk factors for central retinal vein occlusion (CRVO), particularly in patients over 60 with a history of hypertension, diabetes mellitus, glaucoma, and hypercoagulable states?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Risk Factors for Central Retinal Vein Occlusion

The primary risk factors for CRVO are older age (particularly 6th-7th decade), glaucoma, systemic hypertension, and diabetes mellitus, with glaucoma being the most important ocular association. 1

Age-Related Risk

  • Older age is the single most important risk factor for both CRVO and BRVO, with the most common age range being the 6th to 7th decade of life 1
  • RVOs are relatively uncommon in individuals under age 40 1
  • The risk of hypertension-associated CRVO increases with advancing age, with greater odds ratios in older patients 2

Ocular Risk Factors

  • Glaucoma is the most common ocular association with CRVO and represents the strongest independent predictor (adjusted OR 4.75) 1, 3
  • Elevated intraocular pressure and ocular hypertension increase CRVO risk 1
  • Prior RVO in one eye confers a 1% per year risk of developing CRVO in the fellow eye 1

Systemic Vascular Risk Factors

  • Systemic arterial hypertension is a major risk factor, though it is more strongly associated with BRVO than CRVO 1, 2
  • Diabetes mellitus increases CRVO risk independently 1, 2
  • Arteriosclerosis contributes to RVO pathogenesis 1
  • Hyperlipidemia has been identified as a risk factor 2, 4
  • Carotid occlusive disease increases CRVO risk 1
  • Sleep apnea is an additional vascular risk factor 1

Hypercoagulable States and Hematologic Factors

  • In patients under 50 years of age, evaluation for hematologic risk factors warrants consideration, though the cost-effectiveness remains controversial 1
  • Elevated homocysteine levels have been associated with CRVO in selected cases 1
  • Activated protein C resistance (APC-R) appears as a risk factor in 25% of CRVO patients across all ages 4
  • Factor V Leiden and homocysteinemia may contribute more to CRVO than BRVO development, though uniform agreement is lacking 1
  • Hypercoagulability states increase CRVO risk, particularly in younger patients 2, 5

Additional Systemic Associations

  • Systemic lupus erythematosus increases CRVO incidence 3.5-fold compared to control populations 1
  • Kidney disease is associated with increased CRVO risk 2
  • Cardiovascular disease and atrial fibrillation show associations with CRVO 2, 3

Important Clinical Caveats

  • Patients with CRVO have higher mortality rates than age-matched controls due to increased prevalence of cardiovascular disease and diabetes, making communication with primary care providers essential 1
  • The pathogenesis differs between CRVO and BRVO: CRVO relates more to ocular factors (especially glaucoma) and systemic hypercoagulability, while BRVO relates more to local vascular factors at arteriovenous crossing points 1
  • Retinal phlebitis may be associated with RVO, though distinguishing true inflammatory vasculitis from thrombotic occlusions is critical 1, 6
  • Routine testing for heritable thrombophilias lacks evidence support in most RVO patients 7

Risk Factor Management Priority

Optimizing control of systemic arterial hypertension, diabetes, serum lipid levels, and intraocular pressure to control glaucoma are all critical in managing systemic risk factors 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Central retinal vein occlusion risk profile: a case-control study.

European journal of ophthalmology, 2003

Research

Central retinal vein occlusion case-control study.

American journal of ophthalmology, 2007

Research

Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2007

Guideline

Etiologies of Retinal Vasculitides by Vascular Compartment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Retinal vein thrombosis: pathogenesis and management.

Journal of thrombosis and haemostasis : JTH, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.